Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Vance

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Optometry and Physiological Optics|April 1, 1980
Central visual field contributions to the visual-evoked responseJ R Vance, R Jones
Clinical Pharmacy|November 1, 1983
Furosemide-associated ototoxicityJ M DeVito, J R Vance
American Journal of Hospital Pharmacy|February 1, 1985
In vivo accuracy of gravity-flow i.v. infusion systemsR E Crass, J R Vance
The Journal of Biological Chemistry|March 30, 2001
Uncoupling of 3'-phosphatase and 5'-kinase functions in budding yeast. Characterization of Saccharomyces cerevisiae DNA 3'-phosphatase (TPP1)J R Vance, T E Wilson
Molecular and Cellular Biology|October 5, 2001
Repair of DNA strand breaks by the overlapping functions of lesion-specific and non-lesion-specific DNA 3' phosphatasesJ R Vance, T E Wilson
Chemical Communications (Cambridge, England)|March 25, 2017
Thermally driven bubble evolution at a heater wire in water characterized by high-speed transmission electron microscopyJ R Vance, S J Dillon
Biochemical Pharmacology|July 21, 1999
Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridoneJ R Vance, K F Bastow
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2000
Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiaeM H Woo, J R Vance, M A Bjornsti
The Journal of Biological Chemistry|May 16, 2000
Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediateJ Fertala, J R Vance, P Pourquier, et al.
Anticancer Research|January 19, 1999
The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazonesM C Miller, C N Stineman, J R Vance, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Optometry and Physiological Optics|April 1, 1980
Central visual field contributions to the visual-evoked responseJ R Vance, R Jones
Clinical Pharmacy|November 1, 1983
Furosemide-associated ototoxicityJ M DeVito, J R Vance
American Journal of Hospital Pharmacy|February 1, 1985
In vivo accuracy of gravity-flow i.v. infusion systemsR E Crass, J R Vance
The Journal of Biological Chemistry|March 30, 2001
Uncoupling of 3'-phosphatase and 5'-kinase functions in budding yeast. Characterization of Saccharomyces cerevisiae DNA 3'-phosphatase (TPP1)J R Vance, T E Wilson
Molecular and Cellular Biology|October 5, 2001
Repair of DNA strand breaks by the overlapping functions of lesion-specific and non-lesion-specific DNA 3' phosphatasesJ R Vance, T E Wilson
Chemical Communications (Cambridge, England)|March 25, 2017
Thermally driven bubble evolution at a heater wire in water characterized by high-speed transmission electron microscopyJ R Vance, S J Dillon
Biochemical Pharmacology|July 21, 1999
Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridoneJ R Vance, K F Bastow
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2000
Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiaeM H Woo, J R Vance, M A Bjornsti
The Journal of Biological Chemistry|May 16, 2000
Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediateJ Fertala, J R Vance, P Pourquier, et al.
Anticancer Research|January 19, 1999
The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazonesM C Miller, C N Stineman, J R Vance, et al.
Pageof 2